Instalab

Free Carnitine Test

See whether your cells have the fuel they need to burn fat for energy, especially if you are on dialysis, taking certain medications, or feeling unexplained muscle weakness.

Should you take a Free Carnitine test?

This test is most useful if any of these apply to you.

On Dialysis or Living With Advanced Kidney Disease
Dialysis strips carnitine from your blood. This test shows whether deficiency is fueling cramps, anemia, or blood pressure crashes during sessions.
Taking Long-Term Valproic Acid or Other Carnitine-Depleting Drugs
Some medications quietly drain your carnitine pool. This test catches the drop before muscle weakness or liver issues appear.
Family History of Primary Carnitine Deficiency
Inherited transport defects can cause heart muscle disease and metabolic crises. This test is a first step in confirming or ruling out a familial pattern.
Living With Unexplained Muscle Weakness or Fatigue
When standard labs look normal but your energy and strength have dropped, this test asks whether your cells can still burn fat for fuel.

About Free Carnitine

Your body cannot make energy from fat unless it can shuttle fat molecules into the energy-producing compartments inside your cells (the mitochondria). Free carnitine is the molecule that does that shuttling. When levels run low, fat-burning slows down, muscles tire faster, and the heart, kidneys, and brain can all feel the impact.

Most healthy adults make and absorb enough carnitine without thinking about it. The people who benefit most from checking this number are on dialysis, taking medications known to drain carnitine, dealing with unexplained muscle weakness or fatigue, or carrying a family history of inherited carnitine transport problems.

What Free Carnitine Actually Does

Free carnitine is a vitamin-like molecule built from two amino acids (lysine and methionine). About three quarters of your supply comes from animal foods like red meat, poultry, fish, and dairy. The rest your body makes in the liver, kidney, and brain. Your kidneys then quietly conserve it through a transporter called OCTN2, reabsorbing roughly 95% of what gets filtered.

Inside cells, free carnitine grabs onto long-chain fats and carries them into the mitochondria, where they are broken down for energy. Muscle holds the largest pool of carnitine in the body, but muscle cannot make its own and depends entirely on what circulates in the blood. That is why a low blood reading can ripple outward into muscle weakness, fatigue, and heart strain.

Kidney Disease and Dialysis

This is where free carnitine matters most for adults. Hemodialysis strips carnitine out of the blood, and damaged kidneys also synthesize and reabsorb less of it. The result is a chronic deficit that contributes to muscle cramps, treatment-resistant anemia, blood pressure crashes during dialysis (intradialytic hypotension), and fatigue.

In a study of pediatric hemodialysis, 54.8% of children were carnitine deficient, and the deficient group had more cramping and blood pressure drops during their sessions. In peritoneal dialysis with diabetic kidney disease, higher serum free carnitine tracked with better preserved residual kidney function. A six-month course of L-carnitine in this group preserved residual function and urine output while raising free carnitine and several acylcarnitines.

What this means for you: if you are on dialysis or have advanced kidney disease, knowing your free carnitine number is a concrete way to understand whether muscle cramps, anemia, or hypotension during sessions might have a fixable metabolic cause.

Inherited Carnitine Deficiency

Some people inherit two faulty copies of the SLC22A5 gene, which codes for the kidney's carnitine reabsorption transporter (OCTN2). Without it, carnitine washes out in the urine. This condition, called primary carnitine deficiency, can cause heart muscle disease (cardiomyopathy), low blood sugar crises, liver problems, muscle weakness, and in rare cases sudden cardiac death, often appearing in early childhood. Some adults carry the condition silently and only learn about it when their newborn child screens positive.

If a family member has been diagnosed with this condition, or if you have unexplained cardiomyopathy or recurrent metabolic crises, a free carnitine measurement is one of the first steps in working up the diagnosis.

Heart and Metabolic Connections

Beyond the rare inherited disorder, the carnitine system also reflects how well your cells are managing fat as a fuel. In a study of 209 people with heart failure, free carnitine and the broader carnitine profile helped distinguish ischemic from non-ischemic causes and tracked with prognosis. In coronary artery disease, elevated acylcarnitines (the fat-loaded forms of carnitine) signal a mismatch between fat and glucose burning that runs alongside disease severity.

In a cohort of 2,519 patients with suspected stable angina, several carnitine pathway metabolites predicted long-term risk of developing type 2 diabetes, suggesting that disturbances in fat oxidation appear well before blood sugar moves out of range.

Cognitive Decline in Women

A 125-person study across two independent cohorts found that women with mild cognitive impairment or early Alzheimer's disease had lower plasma free carnitine than healthy women, and lower levels tracked with worse cognition and higher amyloid and tau burden. The same pattern was not seen in men. The finding is preliminary, but it points to a sex-specific window where free carnitine may flag mitochondrial trouble in the brain before symptoms become severe.

Frailty, Sarcopenia, and Aging

In older adults, lower serum free carnitine has been associated with frailty, lower muscle mass, and worse nutritional status. In a study of 114 preoperative gastrointestinal cancer patients, free carnitine tracked with sarcopenia and overall nutritional status. In 259 hemodialysis patients, free carnitine and the C2-to-C0 ratio (a sign of how loaded the carnitine pool is with fatty acids) were independently linked to sarcopenia and prognosis.

Reference Ranges

There is no single universally agreed-upon clinical cutpoint for adult free carnitine in preventive medicine. Most numbers below come from specific research populations using lab methods that measure many small molecules at once on serum or dried blood spots. Your lab may report different cutoffs and units. Compare your results within the same lab over time for the most meaningful trend.

ContextTypical Range or CutoffWhat It Suggests
Healthy adult serum (Belgian reference cohort)About 36 to 53 micromoles per liter (median 44)Typical adult range
Newborn screening (dried blood spot)Below 10 micromoles per literTriggers evaluation for primary carnitine deficiency
ESPEN ratio guidanceAcyl-to-free carnitine ratio above 0.4Suggests functional carnitine deficiency
Hemodialysis (research-stratified bands)80 to 199, 200 to 299, or 300+ micromoles per literBoth very low and very high bands linked to more cramping and hypotension

Source: Rousseau et al. (Belgian reference); McHugh et al. and Crefcoeur et al. (newborn screening); Berger et al. (ESPEN); Zhang et al. (hemodialysis). The ratio of acylcarnitines to free carnitine is often more informative than free carnitine alone, because it captures whether the system is jammed up with unprocessed fats.

Why Higher Is Not Always Better

If free carnitine helps your cells burn fat, you might assume more is always better. The evidence does not support that. In a hemodialysis study, patients with very high plasma free carnitine (above 300 micromoles per liter) had more cramping and hypotension than those in a moderate range. A systematic review also flagged that prolonged L-carnitine supplementation in healthy people raises a metabolite called TMAO (trimethylamine-N-oxide), which has been linked to cardiovascular risk. Free carnitine is not a number to push as high as possible. The goal is sufficiency, not excess.

Tracking Your Trend

A single free carnitine reading is most useful as a starting point. Levels shift with diet, kidney function, medications, and illness. If you are starting or stopping L-carnitine supplementation, beginning a new medication that depletes carnitine (such as valproic acid), entering or stepping up dialysis, or testing for a suspected inherited condition, plan to check again in 8 to 12 weeks to see whether the number is moving in the direction you expect.

If you are using this test as part of a broader metabolic checkup, an annual measurement is reasonable. People on chronic hemodialysis or taking long-term carnitine-depleting medications benefit from more frequent testing, often every 6 months, to catch deficiency before symptoms appear.

What to Do With an Abnormal Result

A low free carnitine result is not a diagnosis on its own. The first step is to repeat the test alongside total carnitine and a full acylcarnitine profile, because the ratios reveal more than any single number. From there, the workup typically branches based on the clinical picture: a metabolic geneticist if you suspect an inherited transport defect, a nephrologist if you are on dialysis, an endocrinologist or cardiologist if heart muscle changes or unexplained cardiomyopathy are present.

A high free carnitine reading in someone taking L-carnitine supplements usually just means the dose is high. In that case, working with your prescriber to adjust the dose and rechecking in 8 to 12 weeks is the simplest path. A high reading without supplementation is unusual and worth investigating with your doctor.

When Results Can Be Misleading

  • Recent supplementation: taking L-carnitine, acetyl-L-carnitine, or propionyl-L-carnitine in the days before the draw will raise your number, sometimes substantially. If you want a baseline, hold supplements for at least a week and confirm timing with your physician.
  • Acute illness or critical care recovery: an ICU stay or recent severe illness can shift the carnitine profile for weeks afterward, and the change may not reflect your usual baseline.
  • Pregnancy: plasma free carnitine falls during pregnancy as renal clearance rises, so values during pregnancy should not be compared to non-pregnant reference ranges.
  • Refeeding after severe malnutrition: in eating disorder recovery, free carnitine often drops during refeeding and can be misread as a primary problem.

What Moves This Biomarker

Evidence-backed interventions that affect your Free Carnitine level

Increase
Take oral L-carnitine
Oral L-carnitine reliably raises plasma free carnitine across populations including dialysis patients, type 2 diabetes, healthy adults, and cancer patients. In a study of 32 people with type 2 diabetes, 12 weeks of 2,970 mg per day raised plasma free carnitine and skeletal muscle acetylcarnitine, and improved insulin sensitivity. Whether this translates into long-term clinical benefit depends on the specific population and condition. Long-term supplementation in healthy adults raises plasma TMAO, a metabolite linked in some studies to cardiovascular risk.
SupplementStrong Evidence
Increase
Receive intravenous L-carnitine during hemodialysis
IV L-carnitine given during dialysis sessions raises serum free carnitine and total carnitine. In a study of 80 dialysis patients, supplementation reduced muscle cramping and improved hemoglobin levels, particularly in those who had been on dialysis for over 4 years. A randomized trial of 59 hemodialysis patients showed that reducing supplementation to once weekly significantly lowered plasma and red blood cell carnitine.
MedicationStrong Evidence
Decrease
Take valproic acid (an anti-seizure medication)
Valproic acid genuinely depletes carnitine by forming valproyl-carnitine and impairing carnitine biosynthesis. This can lead to symptomatic carnitine deficiency, high blood ammonia, and in severe cases liver toxicity. L-carnitine supplementation may improve survival in severe valproic acid hepatotoxicity. If you take valproic acid long-term, your carnitine status is worth tracking, especially during illness or dose changes.
MedicationStrong Evidence
Increase
Eat animal-source foods (red meat, poultry, fish, dairy)
About 75% of body carnitine comes from diet, primarily from animal foods. People on strict plant-based diets or with severe malnutrition tend to run lower free carnitine. In a study of 91 severely malnourished eating disorder patients, low carnitine during refeeding was common and was associated with declines in hemoglobin and worse baseline liver impairment.
DietModerate Evidence
Decrease
Take pivoxil-conjugated antibiotics
Pivoxil-containing antibiotics generate pivalate, which combines with carnitine and is excreted in urine, lowering free carnitine. A real-world data analysis in children found the risk in routine clinical use was not significantly higher than other antibiotics, but prolonged or repeated courses can produce meaningful deficits, particularly in young children.
MedicationModerate Evidence
Decrease
Take oral semaglutide (an excipient-related effect)
A case report described carnitine deficiency caused by salcaprozic acid sodium (SNAC), an absorption enhancer in oral semaglutide, in a patient with an underlying acyl-CoA dehydrogenase deficiency. SNAC binds carnitine and increases its excretion. The clinical relevance for healthy adults on oral semaglutide is unclear, but those with underlying fatty acid oxidation disorders should be monitored.
MedicationModest Evidence

Frequently Asked Questions

References

33 studies
  1. Dambrova M, Makrecka-kuka M, Kuka J, Vilskersts R, Nordberg DOT, Attwood MM, Wishart D, Liepinsh E, Schiöth HPharmacological Reviews2022
  2. Jager EA, Schaafsma M, Van Der Klauw MM, Heiner-fokkema MR, Derks TGJournal of Inherited Metabolic Disease2022